Last updated: January 31, 2025
Sponsor: Aesculap AG
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Polyglactin 910 in emergency or elective laparotomy or laparoscopic surgery
Novosyn® in emergency or elective laparotomy or laparoscopic surgery
Clinical Study ID
NCT05966961
AAG-G-H-2201
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients undergoing an emergency or elective laparotomy or laparoscopic surgery.
Written informed consent
Age≥ 18 years
Not incapacitated patient
Exclusion
Exclusion Criteria:
- No exclusion criteria except patients with allergy or hypersensitivity tochlorhexidine
Study Design
Total Participants: 2998
Treatment Group(s): 2
Primary Treatment: Polyglactin 910 in emergency or elective laparotomy or laparoscopic surgery
Phase:
Study Start date:
September 18, 2023
Estimated Completion Date:
August 31, 2028
Connect with a study center
Pineta Grande Hospital
Napoli,
ItalyActive - Recruiting
Hospital Clínico San Carlos
Madrid,
SpainActive - Recruiting
Hospital Universitario Virgen del Rocío
Sevilla,
SpainActive - Recruiting
Hospital Universitario de Canarias
Sta. Cruz de Tenerife,
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.